$558 Million is the total value of Rock Springs Capital Management LP's 78 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $28,189,000 | +20.2% | 340,000 | +2.7% | 5.05% | -6.6% |
| MRK | New | MERCK & CO INC NEW | $27,479,000 | – | 475,000 | +100.0% | 4.93% | – |
| MDT | New | MEDTRONIC INC | $26,460,000 | – | 415,000 | +100.0% | 4.74% | – |
| ITMN | Buy | INTERMUNE INC | $23,753,000 | +73.1% | 538,000 | +31.2% | 4.26% | +34.6% |
| MCK | Buy | MCKESSON CORP | $22,159,000 | +37.2% | 119,000 | +30.1% | 3.97% | +6.6% |
| BIIB | Buy | BIOGEN IDEC INC | $18,919,000 | +12.0% | 60,000 | +8.6% | 3.39% | -13.0% |
| THOR | Buy | THORATEC CORP | $17,158,000 | +19.5% | 492,200 | +22.7% | 3.08% | -7.1% |
| B108PS | Buy | ACTAVIS PLC | $14,666,000 | +26.7% | 65,750 | +16.9% | 2.63% | -1.5% |
| CELG | Buy | CELGENE CORP | $13,741,000 | +27.8% | 160,000 | +107.8% | 2.46% | -0.6% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $13,398,000 | +81.6% | 85,750 | +76.8% | 2.40% | +41.1% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $12,744,000 | -1.2% | 108,000 | +0.7% | 2.28% | -23.2% |
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $11,625,000 | +15.7% | 775,000 | +3.3% | 2.08% | -10.1% |
| HUM | Buy | HUMANA INC | $9,260,000 | +25.4% | 72,500 | +10.7% | 1.66% | -2.5% |
| CVS | Buy | CVS CAREMARK CORPORATION | $9,139,000 | +8.0% | 121,250 | +7.3% | 1.64% | -16.0% |
| CI | New | CIGNA CORPORATION | $8,737,000 | – | 95,000 | +100.0% | 1.57% | – |
| ISRG | Buy | INTUITIVE SURGICAL INC | $8,668,000 | +7.0% | 21,050 | +13.8% | 1.55% | -16.9% |
| COO | Buy | COOPER COS INC | $8,538,000 | +2.7% | 63,000 | +4.1% | 1.53% | -20.1% |
| HRC | New | HILL ROM HLDGS INC | $8,094,000 | – | 195,000 | +100.0% | 1.45% | – |
| ATHN | Buy | ATHENAHEALTH INC | $7,789,000 | +149.2% | 62,250 | +219.2% | 1.40% | +93.8% |
| ILMN | Buy | ILLUMINA INC | $7,677,000 | +21.5% | 43,000 | +1.2% | 1.38% | -5.5% |
| RTIX | Buy | RTI SURGICAL INC | $7,613,000 | +171.9% | 1,750,000 | +155.0% | 1.36% | +111.3% |
| AET | New | AETNA INC NEW | $7,500,000 | – | 92,500 | +100.0% | 1.34% | – |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $7,142,000 | +67.3% | 77,750 | +27.5% | 1.28% | +30.1% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $6,968,000 | -0.3% | 55,250 | +4.2% | 1.25% | -22.5% |
| STJ | New | ST JUDE MED INC | $6,925,000 | – | 100,000 | +100.0% | 1.24% | – |
| TMH | Buy | TEAM HEALTH HOLDINGS INC | $6,093,000 | +12.3% | 122,000 | +0.6% | 1.09% | -12.7% |
| WAG | Buy | WALGREEN CO | $5,930,000 | +27.4% | 80,000 | +13.5% | 1.06% | -1.0% |
| EVHC | Buy | ENVISION HEALTHCARE HLDGS IN | $5,925,000 | +27.4% | 165,000 | +20.0% | 1.06% | -1.0% |
| RAD | New | RITE AID CORP | $5,736,000 | – | 800,000 | +100.0% | 1.03% | – |
| OREX | Buy | OREXIGEN THERAPEUTICS INC | $5,593,000 | +3.7% | 905,000 | +9.0% | 1.00% | -19.4% |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $5,460,000 | – | 120,000 | +100.0% | 0.98% | – |
| CAH | Buy | CARDINAL HEALTH INC | $5,416,000 | +1.8% | 79,000 | +3.9% | 0.97% | -20.9% |
| THRX | Buy | THERAVANCE INC | $5,360,000 | +108.1% | 180,000 | +116.2% | 0.96% | +61.8% |
| MWIV | New | MWI VETERINARY SUPPLY INC | $5,360,000 | – | 37,750 | +100.0% | 0.96% | – |
| INCY | Buy | INCYTE CORP | $5,348,000 | +57.3% | 94,750 | +49.2% | 0.96% | +22.3% |
| TSRO | Buy | TESARO INC | $5,133,000 | +34.4% | 165,000 | +27.4% | 0.92% | +4.4% |
| HTWR | Buy | HEARTWARE INTL INC | $5,089,000 | +8.5% | 57,500 | +15.0% | 0.91% | -15.7% |
| HCA | Buy | HCA HOLDINGS INC | $4,933,000 | +40.2% | 87,500 | +30.6% | 0.88% | +9.1% |
| SRCL | Buy | STERICYCLE INC | $4,914,000 | +39.5% | 41,500 | +33.9% | 0.88% | +8.5% |
| PCYC | Buy | PHARMACYCLICS INC | $4,867,000 | +54.2% | 54,250 | +72.2% | 0.87% | +19.9% |
| KIN | Buy | KINDRED BIOSCIENCES INC | $4,623,000 | +169.7% | 248,000 | +168.1% | 0.83% | +109.9% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $4,600,000 | -4.8% | 310,000 | +3.3% | 0.82% | -25.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $4,379,000 | +286.8% | 46,250 | +189.1% | 0.78% | +200.8% |
| FEIC | Buy | FEI CO | $4,174,000 | +47.3% | 46,000 | +67.3% | 0.75% | +14.5% |
| CO | Buy | CHINA CORD BLOOD CORP | $4,140,000 | +44.3% | 750,000 | +4.5% | 0.74% | +12.1% |
| CYBX | New | CYBERONICS INC | $4,029,000 | – | 64,500 | +100.0% | 0.72% | – |
| AVNR | Buy | AVANIR PHARMACEUTICALS INCcl a new | $3,948,000 | +258.6% | 700,000 | +133.3% | 0.71% | +178.7% |
| MDCO | Buy | MEDICINES CO | $3,926,000 | +15.1% | 135,100 | +12.6% | 0.70% | -10.5% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $3,813,000 | +27.7% | 71,250 | +43.9% | 0.68% | -0.7% |
| ABCO | Buy | ADVISORY BRD CO | $3,756,000 | +88.1% | 72,500 | +133.3% | 0.67% | +46.0% |
| CVD | Buy | COVANCE INC | $3,680,000 | +9.0% | 43,000 | +32.3% | 0.66% | -15.3% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $3,573,000 | -16.7% | 15,100 | +16.2% | 0.64% | -35.2% |
| VSAR | New | VERSARTIS INC | $3,484,000 | – | 124,255 | +100.0% | 0.62% | – |
| PRTA | Buy | PROTHENA CORP PLC | $3,383,000 | +35.9% | 150,000 | +130.8% | 0.61% | +5.7% |
| TNDM | New | TANDEM DIABETES CARE INC | $3,171,000 | – | 195,000 | +100.0% | 0.57% | – |
| WX | Buy | WUXI PHARMATECH CAYMAN INC | $3,171,000 | +63.9% | 96,500 | +83.8% | 0.57% | +27.6% |
| RLYP | New | RELYPSA INC | $3,064,000 | – | 126,000 | +100.0% | 0.55% | – |
| CFN | New | CAREFUSION CORP | $3,016,000 | – | 68,000 | +100.0% | 0.54% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $2,940,000 | +16.8% | 65,500 | +27.2% | 0.53% | -9.3% |
| AGN | New | ALLERGAN INC | $2,750,000 | – | 16,250 | +100.0% | 0.49% | – |
| CBST | Buy | CUBIST PHARMACEUTICALS INC | $2,723,000 | +24.1% | 39,000 | +30.0% | 0.49% | -3.6% |
| NVAX | Buy | NOVAVAX INC | $2,633,000 | +78.9% | 570,000 | +75.4% | 0.47% | +38.8% |
| ALKS | Buy | ALKERMES PLC | $2,076,000 | +32.7% | 41,250 | +16.2% | 0.37% | +3.0% |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $1,943,000 | +67.6% | 152,500 | +56.4% | 0.35% | +30.3% |
| ARWR | Buy | ARROWHEAD RESH CORP | $1,646,000 | +33.6% | 115,000 | +53.3% | 0.30% | +3.9% |
| TBPH | New | THERAVANCE BIOPHARMA INC | $1,594,000 | – | 50,000 | +100.0% | 0.29% | – |
| NVDQ | New | NOVADAQ TECHNOLOGIES INC | $1,483,000 | – | 90,000 | +100.0% | 0.27% | – |
| ETRM | Buy | ENTEROMEDICS INC | $1,326,000 | +12.1% | 850,000 | +30.8% | 0.24% | -12.8% |
| CERU | New | CERULEAN PHARMA INC | $497,000 | – | 85,635 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 43 | Q2 2024 | 4.0% |
| NEUROCRINE BIOSCIENCES INC | 42 | Q2 2024 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 42 | Q2 2024 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 42 | Q2 2024 | 2.4% |
| ACADIA HEALTHCARE COMPANY IN | 41 | Q2 2024 | 4.4% |
| ASCENDIS PHARMA A/S | 38 | Q2 2024 | 1.3% |
| BIOMARIN PHARMACEUTICAL INC | 38 | Q2 2024 | 1.3% |
| MACROGENICS INC | 38 | Q2 2024 | 0.5% |
| AMICUS THERAPEUTICS INC | 37 | Q2 2024 | 0.6% |
| ADAPTIMMUNE THERAPEUTICS PLC | 37 | Q2 2024 | 1.2% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Travere Therapeutics, Inc. | May 01, 2024 | 4,411,983 | 5.8% |
| Xilio Therapeutics, Inc. | April 05, 2024 | 3,003,259 | 8.7% |
| Aclaris Therapeutics, Inc. | February 14, 2024 | 2,998,495 | 4.2% |
| AGIOS PHARMACEUTICALS, INC. | February 14, 2024 | 2,152,173 | 3.8% |
| Gamida Cell Ltd.Sold out | February 14, 2024 | 0 | 0.0% |
| Immunocore Holdings plc | February 14, 2024 | 2,661,507 | 5.4% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,681,174 | 6.0% |
| Mereo BioPharma Group plc | February 14, 2024 | 39,919,255 | 5.7% |
| SPRUCE BIOSCIENCES, INC. | February 14, 2024 | 2,609,125 | 6.4% |
| Spyre Therapeutics, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-01 |
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.